The global cancer immunotherapy market size is likely to reach USD 126.9 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 9.6% during the forecast period. Increasing patient pool and higher mortality rate are augmenting the need for cancer immunotherapy globally. Furthermore, increasing number of approvals for new immunotherapeutic drugs is driving the global market.
Cancer
immunotherapy has emerged as a new avenue for revenue generation for
pharmaceutical companies. In addition, adverse effects, such as recurrence of
cancer and organ failure, associated with conventional chemotherapies and
rising demand for technologically advanced healthcare solutions are boosting
the demand for immunotherapies. Moreover, introduction of newer drug classes,
such as target receptors for multiple myeloma and checkpoint inhibitors, is
poised to make way for advanced therapeutics in the market.
Introduction
of new molecules has been proving to be beneficial for patients who are not
responding to chemotherapy. Several new immunotherapeutic options, such as
immunomodulators and CAR-T cell therapy, are in the pipeline and are being
tested for their ability to provide better cancer treatment.
Monoclonal
antibodies are the most widely used immunotherapeutic drugs globally. Development
of monoclonal antibodies as effective immunotherapeutic options started after
the approval of Blincyto (blinatumomab) by Amgen, a bispecific antibody that
targets B-cell lymphoblastic leukemia. Increasing R&D pertaining to the use
of monoclonal bodies as naked antigen binding antibodies, conjugated, and
bispecific antibodies is resulting in discovery of new therapeutic options for
cancer treatment.
For Full Research Report On Cancer Immunotherapy Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/cancer-immunotherapy-market
Further key
findings from the report suggest:
- Majority of immunotherapy
drugs are being used in treatment of cancer of lung, breast, and prostate
- Monoclonal antibodies
emerged as the largest segment because of increasing regulatory approvals
and higher efficacy
- Lung cancer accounted for
the largest share in 2018 and will continue to dominate the market through
2025
- North America was the
leading revenue contributor in the market in 2018. Rising incidence of
cancer and increasing demand for novel technologies are facilitating the
dominance of the region during the forecast period
- Europe is projected to
witness rapid growth during the forecast period owing to rapid adoption of
advanced cancer therapeutics for effective treatment
- Some of the key players are
Amgen, Inc.; AstraZeneca; F. Hoffmann La Roche Ltd.; Bayer AG;
Bristol-Myers Squibb Company; Eli Lilly and Company; Merck and Co., Inc.;
Novartis AG; and Pfizer, Inc.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/cancer-immunotherapy-market/request/rs1
Grand View Research has segmented
the global cancer immunotherapy market based on product, cancer type, and
region:
Cancer
Immunotherapy Product Outlook (Revenue, USD Billion, 2015 - 2026)
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies
and Cancer Vaccines
Cancer
Immunotherapy Cancer Type Outlook (Revenue, USD Billion, 2015 - 2026)
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head and Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
Cancer
Immunotherapy Regional Outlook (Revenue, USD Billion, 2015 - 2026)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- U.A.E.
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment